Brief: Immutep Announces First-In-Human Phase I Study Of IMP761 Progresses To Dose Escalation Portion Of Trial

Immutep

17/10/2024 13:15

Oct 17 (Reuters) - Immutep Ltd  IMM.AX :
    * IMMUTEP ANNOUNCES FIRST-IN-HUMAN PHASE I STUDY OF IMP761
PROGRESSES TO DOSE ESCALATION PORTION OF TRIAL
    * IMMUTEP LTD - TRIAL PROGRESSES TO PART B DOSE ESCALATION
PHASE
    * IMMUTEP LTD - FIRST SAFETY DATA ANTICIPATED BEFORE YEAR
END

Source text for Eikon:  ID:nGNX52zPfX 
Further company coverage:  IMM.AX 

 ((Reuters.Briefs@thomsonreuters.com;))